期刊文献+

淋巴结转移率与甲状腺乳头状癌患者术后复发及预后的相关性 被引量:11

Correlation of lymph node metastasis rate with postoperative recurrence and prognosis in patients with thyroid papillary carcinoma
原文传递
导出
摘要 目的研究淋巴结转移率(lymph node metastatic rate,LR)与甲状腺乳头状癌(papillary thyroid carcinoma,PTC)患者术后复发及预后的相关性。方法回顾性分析2010年1月至2013年6月期间上海市第一人民医院宝山分院收治的62例PTC患者的临床病理资料。根据LR值分为低LR组(<25%,38例)、高LR组(≥25%,24例)。比较两组患者临床病理特点、术后复发及5年生存率,分析预后的影响因素。结果不同年龄、病灶数、病灶直径、TNM分期及淋巴结转移数的患者,LR值比较差异均有统计学意义(P均<0.05);低LR组术后复发低于高LR组(15.8%与41.7%),而5年生存率低LR组高于高LR组(92.1%与63.0%)(P均<0.05);多因素回归LR、TNM分期是PTC患者预后的独立危险因素,而年龄则是独立保护因素(HR分别为1.587、1.714、0.617,P均<0.05)。结论LR可作为PTC患者术后复发及预后独立评估指标之一。 Objective To explore the correlation of of lymph node metastasis rate (LR) with postoperative recurrence and prognosis in patients with thyroid papillary carcinoma (PTC).Methods From January 2010 to June 2013, the clinical data of sixty-two patients with PTC in Baoshan Branch, Shanghai First People′s Hospital were retrospectively analyzed.According to the LR, patients were divided into low LR(<25%) group(38 cases), high LR(≥25%) group (24 cases). The clinical pathological characteristics, postoperative recurrence and 5-year survival rate of the two groups was compared, and the influence factors of prognosis were analyzed.Results There was significant difference in LR among patients with different ages, numbers of lesions, lesion diameters, TNM stages and numbers of lymph node metastasis (P<0.05);compared with high LR group, the recurrence in low LR group was obviously reduced(15.8% vs.41.7%), and 5-year survival rate was significantly increased (92.1% vs.63.0%) (P<0.05). LR and TNM stage were the independent risk factors of prognosis in PTC patients, and age was independent protection factor (HR=1.587, 1.714, 0.617, P<0.05).Conclusion LR can be used as one of postoperative recurrence and prognosis evaluation indicators of PTC.
作者 金海龙 张毅 潘炯 Jin Hailong;Zhang Yi;Pan Jiong(Department of Breast Surgery,Baoshan Branch,Shanghai First People's Hospital,Shanghai 200940,China)
出处 《中国综合临床》 2019年第1期14-17,共4页 Clinical Medicine of China
关键词 甲状腺乳头状癌 淋巴结转移率 复发 预后 Thyroid papillary carcinoma Lymph node metastatic rate Recurrence Prognosis
  • 相关文献

参考文献3

二级参考文献23

  • 1Jemal A, Siegel R,Xu J, et al. Cancer statistics, 2010 [ J ] . CACancer J Clin, 2010, 60 ( 5 ): 277-300.
  • 2O'Connell JB, Maggard MA, Ko CY. Colon cancer survival rates withthe new American Joint Committee on Cancer sixth edition staging[ J ].J Natl Cancer Inst, 2004, 96 ( 19 ) : 1420-1425.
  • 3Kritsanasakul A, Boonpipattanapong T, Wanitsuwan W, et al. Impactof lymph node retrieval on surgical outcomes in colorectal cancers[ J ].J Surg Oncol,2012,106 ( 3 ) : 238-242.
  • 4Chang GJ, Rodriguez-Bigas MA, Skibber JM, et al. Lymph nodeevaluation and survival after curative resection of colon cancer :systematic review [ J ] . J Natl Cancer Inst, 2007, 99 ( 6 ) : 433-441.
  • 5Joseph NE, Sigurdson ER, Hanlon AL, et al. Accuracy ofdetermining nodal negativity in colorectal Cancer on the basis of thenumber of nodes retrieved on resection [ J ] . Ann Surg Oncol,2003,10?3): 213-218.
  • 6Rosenberg R, Friederichs J, Schuster T,et al. Prognosis of patientswith colorectal cancer is associated with lymph node ratio : a single-center analysis of 3,026 patients over a 25-year time period [ J ].Ann Surg, 2008,248 ( 6 ) : 968-978.
  • 7Poritz LS, Sehgal R, Hartnett K, et al. Tumor volume and percentpositive lymph nodes as a predictcft- of 5-year survival in colorectalCancer [J] . Surgery? 2011,^0 (4) : 649-655.
  • 8Greene, Frederick L. American joint Committe on Cancer : AJCCCancer Staging Manual ( 6th ed ) [ M ] . New York : Springer,2002 : 113-124.
  • 9Nitti D, Marchet A, Olivieri M, et al. Ratio between metastaticand examined lymph nodes is an independent prognostic factorafter D2 resection for gastric cancer : analysis of a large Europeanmonoinstitutional experience [ J ] . Ann Surg Oncol,2003, 10 ( 9 ):1077-1085.
  • 10Berger AC , Watson JC , Ross EA , et al. The metastatic/examined lymph node ratio is an important prognostic factor afterpancreaticoduodenectomy for pancreatic adenocarcinoma [ J ] . AnnSurg, 2004, 70 ( 3 ) : 235-240.

共引文献12

同被引文献132

引证文献11

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部